Preparatory Work to Assess Adherence to Oral Chemotherapy

120 patients with Chronic Myeloid Leukemia (CML) who are currently prescribed an oral
anti-cancer agent from up to 6 CCDR NCORP sites to complete a brief interviewer administered
survey to assess medication adherence and related factors.

Inclusion Criteria:

- Patient is diagnosed with Chronic Myeloid Leukemia (CML) and is receiving care for CML
at a participating CCDR NCORP practice,

- Patient had been prescribed one of the following oral anticancer agents for CML for
≥30 days (Imatinib, Nilotinib, Dasatinib, Bosutinib, Ponatinib). Prior use of any of
these medications is allowed, as long as they have been on a stable regimen for at
least 30 days prior to enrollment.

- Patient is 18 years of age or older

Exclusion Criteria:

- Patient does not speak English or requires an interpreter for medical visits

- Patient is cognitively impaired, as determined by the referring provider